Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

It led to the development of insulin pens, which soon replaced syringes as the way to take the drug for millions of people. Now Dr Reith, who worked in Glasgow and Stirling throughout her career ...

Today marks the end of an era for the Qantas Group with the last remaining QantasLink Boeing 717 jet taking passengers to Australian skies for the final time. The final flight (QF1511) landed in ...

More than 500 million people live with diabetes, and around 783 million are expected to have the condition by 2045.1 Of this population, 5% to 15% have type 1 diabetes (T1D).2 Insulin therapy is ...

"I thought: No insulin? Death is imminent," Wright said. Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi ... 800 million insulin pens a year.

Which insulin brands are in shortage and why? Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter vials. The company said new regulations had ...